Wireless brain sensors market seen reaching $1.6 billion by 2031

Allied Market Research projects the wireless brain sensors market will grow from $677.8 million in 2021 to $1.6 billion by 2031, driven by better sensor technology, rising neurological disease cases and broader telemedicine use. North America led the market in 2024 and is expected to keep the top spot, while Alzheimer’s-related devices and MEG systems show the fastest growth potential.

Why it matters: - The wireless brain sensors market is moving from niche monitoring toward broader clinical use as demand rises for remote brain health tools. - Growth in epilepsy, Alzheimer’s disease, Parkinson’s disease and other neurological conditions is expanding the need for brain monitoring. - Telemedicine and remote patient monitoring are making wireless sensors more relevant for care outside hospitals.

What happened: - Allied Market Research published a market study projecting the wireless brain sensors market will reach $1.6 billion by 2031. - The report values the market at $677.8 million in 2021 and forecasts a 9.0% compound annual growth rate from 2022 to 2031. - The study covers investment opportunities, market size, competition, drivers, restraints and trends.

The details: - Wireless sensors are becoming more accurate and reliable as technology improves. - Research and development spending in neurology and neuroscience is adding momentum to the market. - EEG devices held more than one-third of market revenue in 2021 and are expected to remain the dominant product type by 2031. - MEG devices are projected to grow the fastest, at a 10.1% CAGR during the forecast period. - Sleep monitoring devices are also included in the analysis. - By application, the “others” category held nearly three-fourths of market share in 2021 and is expected to stay dominant by 2031. - Alzheimer’s disease is expected to be the fastest-growing application segment, with a 12.3% CAGR. - Traumatic brain injury, epilepsy and sleep disorders are also part of the report’s application breakdown. - By end user, research and academic institutes accounted for nearly two-fifths of the market in 2021 and are projected to keep the lead. - The “other” end-user segment is expected to grow the fastest, at 11.4% CAGR. - Hospitals and homecare settings are also covered in the study. - North America generated nearly two-fifths of global market share in 2021 and is expected to retain the largest share through 2031. - LAMEA is projected to post the fastest regional CAGR at 10.2%. - Asia-Pacific and Europe are included in the regional analysis.

Between the lines: - The fastest-growing segments point to a market shifting toward higher-value neurological diagnostics and disease-specific monitoring. - North America’s lead suggests established healthcare spending and adoption of digital monitoring tools remain a major advantage. - The report’s emphasis on telemedicine reflects a broader move toward at-home and remote clinical care.

What’s next: - Market investors and manufacturers are likely to focus on the fastest-growing segments, especially Alzheimer’s-related devices, MEG systems and regional opportunities in LAMEA. - The report says future strategy should be guided by revenue-leading and fastest-growing segments across product, application, end user and region. - The company offers a sample PDF report and purchase inquiry option for the study.

The bottom line: - Wireless brain sensors are expected to keep growing as neurological disease management, remote care and sensor accuracy improve.